SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Infinity Pharmaceuticals
An SI Board Since April 2006
Posts SubjectMarks Bans Symbol
210 13 0 INFI
Emcee:  dr.praveen Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
185Unusual volume today, about 30x normal. Happens about once a year. But no newstuck-4/21/2011
184"I like that they have enough resources to get them past several inflectiontuck-4/15/2011
183Article on PI3K Inhibitors: pubs.acs.org Cheers, Tucktuck-4/12/2011
182Infinity's clinical update and 4Q/'10 results: investor.infi.com Cheertuck-3/15/2011
181"From what I understand the Calistoga compound has been doing very well in tuck-2/25/2011
180From what I understand the Calistoga compound has been doing very well in some Brkrw-2/24/2011
179This sort of post is really appreciated.... as you know, I no longer poke arouscaram(o)uche-2/24/2011
178I have been doing some digging on Infinity recently. Their compound targeting tuck-2/24/2011
177Noticed INFI drifting down toward $5 summary of HSP90 lately etc Synta Is HeatiMike McFarland-8/15/2010
176That was DPII, but I don't think that IPI needed anything from that old outfMike McFarland-1/27/2009
175Mike; Kind of has been flying under the radar huh? Interesting rag tag bunch ofSteve Lokness-1/27/2009
174Got close to $9 today, has more than doubled since the lows of late October HerMike McFarland-1/27/2009
173>>Infinity Reacquires Worldwide Rights to Its Hsp90 Inhibitor Program Thurtuck-12/11/2008
172Infinity Announces Global Strategic Alliance With Purdue Pharma and Mundipharma Mike McFarland-11/24/2008
171504 whiffs in P2a prostate cancer trial, shares off 8% after hours: >>Inftuck-7/14/2008
170Infinity Highlights Promising Preclinical Hedgehog Data and Announces First QuarMike McFarland-5/5/2008
169Kosan chemistry prnewswire.com <i> Kosan's third-generation Hsp90 inMike McFarland-4/16/2008
168Infinity's Hedgehog Antagonist Delays Tumor Growth Following Chemotherapy inMike McFarland-4/15/2008
167Preclinical Data Highlighting Potential of Retaspimycin in Treating Non-Small CeMike McFarland-4/15/2008
166Preclinical data for IPI-926 presented investor.ipi.com <i>we look forwardMike McFarland-4/14/2008
165New Data On Infinity's Lead Anti-Cancer Candidates to be Presented At AACR iMike McFarland-4/7/2008
164A little flurry of activity in the last few minutes of trading, something to do Mike McFarland-3/31/2008
163I don't know if I am crying wolf here, but thought I'd make a note of ittuck-2/29/2008
162INFI should finish '08 with $70-80M investor.ipi.com End of '07 INFI haMike McFarland-2/21/2008
161Hi, Mike! Hope the holidays treated you and yours well. I traded INFI a while tuck-1/9/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News